| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,800 |
7,921 |
$825K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,526 |
1,250 |
$80K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,438 |
524 |
$71K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
865 |
564 |
$67K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
620 |
520 |
$44K |
| 99215 |
Prolong outpt/office vis |
539 |
350 |
$43K |
| 96127 |
|
3,588 |
2,496 |
$40K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,008 |
1,057 |
$38K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,957 |
1,115 |
$31K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
483 |
433 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
577 |
293 |
$14K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,003 |
1,282 |
$13K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
972 |
304 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
211 |
189 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,115 |
455 |
$5K |
| 99000 |
|
4,499 |
2,271 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,075 |
1,463 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
965 |
410 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
438 |
241 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
36 |
35 |
$4K |
| 0012A |
|
86 |
72 |
$3K |
| 0011A |
|
74 |
63 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
26 |
25 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
422 |
205 |
$2K |
| 81002 |
|
1,050 |
524 |
$1K |
| 99383 |
|
13 |
12 |
$1K |
| 0071A |
|
21 |
15 |
$765.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
32 |
19 |
$748.68 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
56 |
51 |
$468.29 |
| 81025 |
|
94 |
51 |
$462.57 |
| 71046 |
Radiologic examination, chest; 2 views |
45 |
16 |
$456.80 |
| 0001A |
|
14 |
12 |
$411.81 |
| 90686 |
|
40 |
32 |
$361.21 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16 |
16 |
$246.24 |
| 80305 |
|
24 |
13 |
$153.34 |
| 36416 |
|
114 |
43 |
$47.48 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
30 |
27 |
$23.08 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
89 |
78 |
$8.77 |
| 90687 |
|
915 |
195 |
$0.00 |
| 91300 |
|
17 |
16 |
$0.00 |
| 96160 |
|
72 |
66 |
$0.00 |
| 91301 |
|
107 |
87 |
$0.00 |
| 91307 |
|
29 |
16 |
$0.00 |